Literature DB >> 342676

Alterations in the composition of brain lipids in patients with Creutzfeldt-Jakob disease.

Y Tamai, H Kojima, F Ikuta, T Kumanishi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 342676     DOI： 10.1016/0022-510x(78)90102-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  8 in total

1.  Neurochemical changes in Creutzfeldt-Jakob disease.

Authors:  A Federico; P Annunziata; G Malentacchi
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

2.  Adult pigment type (Peiffer) of sudanophilic leukodystrophy. Pathological and morphometrical studies on two autopsy cases of siblings.

Authors:  R Okeda; T Matsuo; Y Kawahara; Y Eishi; Y Tamai; M Tanaka; M Kamaki; N Tsubota; H Yamadera
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 3.  Ganglioside GD3: structure, cellular distribution, and possible function.

Authors:  T N Seyfried; R K Yu
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

4.  Neutral lipid and sphingolipid composition of the brain of a patient with membranous lipodystrophy.

Authors:  Y Ohtani; S Miura; Y Tamai; H Kojima; H Kashima
Journal:  J Neurol       Date:  1979-03-22       Impact factor: 4.849

5.  Altered gene transcription linked to astrocytes and oligodendrocytes in frontal cortex in Creutzfeldt-Jakob disease.

Authors:  Pol Andres Benito; Mayelin Dominguez Gonzalez; Isidro Ferrer
Journal:  Prion       Date:  2018-07-27       Impact factor: 3.931

6.  Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.

Authors:  M R Higatsberger; G Sperk; H Bernheimer; K S Shannak; O Hornykiewicz
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

7.  Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

Authors:  Paula A Desplats; Christine A Denny; Kristi E Kass; Tim Gilmartin; Steven R Head; J Gregor Sutcliffe; Thomas N Seyfried; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2007-05-22       Impact factor: 5.996

8.  Plasmalogens inhibit APP processing by directly affecting γ-secretase activity in Alzheimer's disease.

Authors:  Tatjana L Rothhaar; Sven Grösgen; Viola J Haupenthal; Verena K Burg; Benjamin Hundsdörfer; Janine Mett; Matthias Riemenschneider; Heike S Grimm; Tobias Hartmann; Marcus O W Grimm
Journal:  ScientificWorldJournal       Date:  2012-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.